| EXEL |
EXELIXIS, INC. |
15 Jan 2026 |
2 |
-$1,232,698 |
4 |
EVP, Research and Development |
16 Jan 2026, 19:02 |
| EXEL |
EXELIXIS, INC. |
21 Nov 2025 |
1 |
$0 |
4 |
EVP, Research and Development |
24 Nov 2025, 19:47 |
| EXEL |
EXELIXIS, INC. |
11 Nov 2025 |
1 |
-$2,056,278 |
4 |
EVP, Research and Development |
13 Nov 2025, 19:12 |
| EXEL |
EXELIXIS, INC. |
08 Oct 2025 |
1 |
$0 |
4 |
EVP, Research & Development |
10 Oct 2025, 18:57 |
| EXEL |
EXELIXIS, INC. |
15 May 2025 |
1 |
-$1,370,442 |
4 |
CSO/EVP Disc & Trans Research |
16 May 2025, 20:58 |
| EXEL |
EXELIXIS, INC. |
01 May 2025 |
1 |
-$58,812 |
4 |
CSO/EVP Disc & Trans Research |
05 May 2025, 19:12 |
| EXEL |
EXELIXIS, INC. |
31 Mar 2025 |
1 |
$0 |
4 |
CSO/EVP Disc & Trans Research |
31 Mar 2025, 19:43 |
| EXEL |
EXELIXIS, INC. |
26 Feb 2025 |
1 |
$0 |
4 |
CSO/EVP Disc & Trans Research |
28 Feb 2025, 20:35 |
| EXEL |
EXELIXIS, INC. |
24 Feb 2025 |
1 |
-$991,772 |
4 |
CSO/EVP Disc & Trans Research |
26 Feb 2025, 20:00 |
| EXEL |
EXELIXIS, INC. |
15 Feb 2025 |
2 |
-$1,006,180 |
4 |
CSO/EVP Disc & Trans Research |
19 Feb 2025, 20:31 |
| EXEL |
EXELIXIS, INC. |
16 Jan 2025 |
2 |
-$841,184 |
4 |
CSO/EVP Disc & Trans Research |
17 Jan 2025, 21:45 |
| EXEL |
EXELIXIS, INC. |
15 Nov 2024 |
1 |
-$449,972 |
4 |
CSO/EVP Disc & Trans Research |
19 Nov 2024, 20:02 |
| EXEL |
EXELIXIS, INC. |
05 Nov 2024 |
3 |
-$1,571,173 |
4 |
CSO/EVP Disc & Trans Research |
07 Nov 2024, 19:44 |
| EXEL |
EXELIXIS, INC. |
30 Oct 2024 |
1 |
-$36,487 |
4 |
CSO/EVP Disc & Trans Research |
01 Nov 2024, 18:43 |
| EXEL |
EXELIXIS, INC. |
12 Aug 2024 |
1 |
-$565,094 |
4 |
CSO/EVP Disc & Trans Research |
14 Aug 2024, 19:12 |
| EXEL |
EXELIXIS, INC. |
07 Aug 2024 |
3 |
-$56,050 |
4 |
CSO/EVP Disc & Trans Research |
09 Aug 2024, 19:32 |
| EXEL |
EXELIXIS, INC. |
15 May 2024 |
3 |
-$474,479 |
4 |
CSO/EVP Disc & Trans Research |
17 May 2024, 19:58 |
| EXEL |
EXELIXIS, INC. |
23 Feb 2024 |
1 |
$0 |
4 |
CSO/EVP Disc & Trans Research |
27 Feb 2024, 18:58 |
| EXEL |
EXELIXIS, INC. |
15 Feb 2024 |
1 |
-$216,746 |
4 |
CSO/EVP Disc & Trans Research |
16 Feb 2024, 19:21 |
| EXEL |
EXELIXIS, INC. |
11 Jan 2024 |
2 |
-$265,313 |
4 |
CSO/EVP Disc & Trans Research |
16 Jan 2024, 20:50 |
| EXEL |
EXELIXIS, INC. |
06 Sep 2023 |
2 |
-$279,711 |
4 |
CSO/EVP Disc & Trans Research |
08 Sep 2023, 22:25 |
| EXEL |
EXELIXIS, INC. |
30 Aug 2023 |
1 |
-$103,362 |
4 |
CSO/EVP Disc & Trans Research |
01 Sep 2023, 21:15 |
| EXEL |
EXELIXIS, INC. |
15 Aug 2023 |
1 |
-$135,083 |
4 |
CSO/EVP Disc & Trans Research |
17 Aug 2023, 21:14 |
| EXEL |
EXELIXIS, INC. |
15 May 2023 |
2 |
-$201,160 |
4 |
CSO/EVP Disc & Trans Research |
17 May 2023, 20:12 |
| EXEL |
EXELIXIS, INC. |
03 Apr 2023 |
1 |
$0 |
4 |
CSO/EVP Disc & Trans Research |
05 Apr 2023, 20:27 |
| EXEL |
EXELIXIS, INC. |
27 Feb 2023 |
6 |
-$227,700 |
4 |
CSO/EVP Disc & Trans Research |
01 Mar 2023, 18:56 |
| EXEL |
EXELIXIS, INC. |
15 Feb 2023 |
1 |
-$27,644 |
4 |
CSO/EVP Disc & Trans Research |
17 Feb 2023, 20:39 |
| EXEL |
EXELIXIS, INC. |
05 Jan 2023 |
1 |
$0 |
4 |
CSO/EVP Disc & Trans Research |
09 Jan 2023, 18:58 |
| EXEL |
EXELIXIS, INC. |
15 Dec 2022 |
0 |
$0 |
3 |
CSO/EVP Disc & Trans Research |
23 Dec 2022, 19:15 |